Indication

Upper respiratory pneumococcal infection

An upper respiratory pneumococcal infection is a localized, non-invasive bacterial illness affecting the upper respiratory tract and adjacent structures—most commonly manifesting as acute otitis media or acute rhinosinusitis. Read more about Upper respiratory pneumococcal infection

230 drugs 112 manufacturers

Advertisement

Drugs that treat it

Common Upper respiratory pneumococcal infection therapies.

Showing 91–99 of 230 drugs

Filter & compare in the drug finder →Opens the drug finder with Upper respiratory pneumococcal infection preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Upper respiratory pneumococcal infection.

An upper respiratory pneumococcal infection is a localized, non-invasive bacterial illness affecting the upper respiratory tract and adjacent structures—most commonly manifesting as acute otitis media or acute rhinosinusitis.

It is caused by *Streptococcus pneumoniae*, a gram-positive organism that colonizes the human nasopharynx and spreads contiguously into mucosal sites.

While it can affect any population, young children, older adults, and individuals with prior viral respiratory illnesses or impaired mucosal clearance are at the greatest risk.

Clinically and pathophysiologically, it is defined by acute mucosal inflammation, purulent exudation, and localized mechanical obstruction, presenting with focal pain, tissue erythema, persistent sinus congestion, or ear drainage.

Personalize your experience

Follow Upper respiratory pneumococcal infection and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it